Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Karuna Therapeutics, Inc. (KRTX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Karuna Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Karuna Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is KRTX. The reporting company's CIK number is 1771917.
The total value of stock buying since 2005 is $18,523,589.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-07-02||Alexandria Venture Investments, Llc||Buy||30,000||16.00||480,000|
|2019-07-02||Healy James (Director)||Buy||700,000||16.00||11,200,000|
|2019-07-02||Chowrira Bharat M (Director)||Buy||5,000||21.88||109,400|
|2019-07-02||Bybee Clinton (10% Owner)||Buy||200,000||16.00||3,200,000|
|2019-07-02||Nelsen Robert (Director)||Buy||200,000||16.00||3,200,000|
|2019-07-01||Chowrira Bharat M (Director)||Buy||5,000||20.55||102,739|
|2019-06-28||Paul Steven M (President & CEO)||Buy||10,000||23.14||231,450|
Insider trading activities including stock purchases, stock sales, and option exercises of KRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Karuna Therapeutics, Inc. (symbol KRTX, CIK number 1771917) see the Securities and Exchange Commission (SEC) website.